Abstract
The ethical dimension of innovation, a hitherto neglected research area, has started attracting scholarly interest. This is of particular relevance considering the increasing rate of ethical infractions that characterise the innovation and technology landscape. Though the need for ethical and responsible innovation is being highlighted in the extant literature, there appears to be a lack of research focus on related unethical practices. In this chapter we draw attention to the concept of unethical innovation process and highlight practices that characterise such a process. Using Theranos, a medical technology firm as our case study, and content analysis as our methodological approach, we explored the characteristics and facilitating factors of the unethical innovation process. The findings highlight eight major related characteristics and eleven major facilitating factors. This chapter makes three significant contributions to the field of innovation management by doing the following: it introduces the concept of unethical innovation process; highlights the major related characteristics; and identifies the major related facilitating factors.
